transdominant TREV fusion protein (Baylor)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametransdominant TREV fusion protein (Baylor)
Drug Alias NameTREV fusion protein gene therapy (Baylor)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaylor College Of Medicine
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A